119 related articles for article (PubMed ID: 10193964)
1. Does wound healing contribute to the eradication of basal cell carcinoma following curettage and electrodessication?
Nouri K; Spencer JM; Taylor JR; Hayag M; DeVoursney J; Shah N
Dermatol Surg; 1999 Mar; 25(3):183-7; discussion 187-8. PubMed ID: 10193964
[TBL] [Abstract][Full Text] [Related]
2. Does inflammation contribute to the eradication of basal cell carcinoma following curettage and electrodesiccation?
Spencer JM; Tannenbaum A; Sloan L; Amonette RA
Dermatol Surg; 1997 Aug; 23(8):625-30; discussion 630-1. PubMed ID: 9256908
[TBL] [Abstract][Full Text] [Related]
3. Cryosurgery and curettage-cryosurgery for basal cell carcinomas of the mid-face.
Samain A; Boullié MC; Duval-Modeste AB; Joly P
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1291-6. PubMed ID: 25354233
[TBL] [Abstract][Full Text] [Related]
4. Effects of biopsy-induced wound healing on residual basal cell and squamous cell carcinomas: rate of tumor regression in excisional specimens.
Swetter SM; Boldrick JC; Pierre P; Wong P; Egbert BM
J Cutan Pathol; 2003 Feb; 30(2):139-46. PubMed ID: 12641794
[TBL] [Abstract][Full Text] [Related]
5. Early Detection of Desiccation and Curettage Failure in the Treatment of Basal Cell Carcinoma.
Woldow AB; Melvin ME
Dermatology; 2016; 232(6):696-699. PubMed ID: 27941318
[TBL] [Abstract][Full Text] [Related]
6. Duplicitous growth of infiltrative basal cell carcinoma: Analysis of clinically undetected tumor extent in a paired case-control study.
Hendrix JD; Parlette HL
Dermatol Surg; 1996 Jun; 22(6):535-9. PubMed ID: 8646468
[TBL] [Abstract][Full Text] [Related]
7. Curettage vs. cryosurgery for superficial basal cell carcinoma: a prospective, randomised and controlled trial.
Backman EJ; Polesie S; Berglund S; Gillstedt M; Sjöholm A; Modin M; Paoli J
J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):1758-1765. PubMed ID: 35543079
[TBL] [Abstract][Full Text] [Related]
8. Surgical excision versus curettage plus cryosurgery in the treatment of basal cell carcinoma.
Kuijpers DI; Thissen MR; Berretty PJ; Ideler FH; Nelemans PJ; Neumann MH
Dermatol Surg; 2007 May; 33(5):579-87. PubMed ID: 17451581
[TBL] [Abstract][Full Text] [Related]
9. Histological and immunohistochemical evaluation of basal cell carcinoma following curettage and electrodessication.
Filho LL; de Oliveira de Avelar Alchorne A; Pereira GC; Lopes LR; de Carvalho TC
Int J Dermatol; 2008 Jun; 47(6):610-4. PubMed ID: 18477158
[TBL] [Abstract][Full Text] [Related]
10. Basal cell carcinoma margin delineation: is curettage useful? A surgical and histological study.
Dika E; Fanti PA; Ismaili A; Misciali C; Vaccari S; Barisani A; Patrizi A
J Dermatolog Treat; 2013 Jun; 24(3):238-42. PubMed ID: 23216407
[TBL] [Abstract][Full Text] [Related]
11. Recurrence rates of aggressive histologic types of basal cell carcinoma after treatment with electrodesiccation and curettage alone.
Blixt E; Nelsen D; Stratman E
Dermatol Surg; 2013 May; 39(5):719-25. PubMed ID: 23379543
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of curettage before excision in clearing surgical margins of nonmelanoma skin cancer.
Chiller K; Passaro D; McCalmont T; Vin-Christian K
Arch Dermatol; 2000 Nov; 136(11):1327-32. PubMed ID: 11074693
[TBL] [Abstract][Full Text] [Related]
13. Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma.
Spencer JM
Dermatol Surg; 2006 Jan; 32(1):63-9. PubMed ID: 16393600
[TBL] [Abstract][Full Text] [Related]
14. Failure of curettage and electrodesiccation for removal of basal cell carcinoma.
Suhge d'Aubermont PC; Bennett RG
Arch Dermatol; 1984 Nov; 120(11):1456-60. PubMed ID: 6497413
[TBL] [Abstract][Full Text] [Related]
15. Incidence of residual basal cell carcinoma in patients who appear tumor free after biopsy.
Holmkvist KA; Rogers GS; Dahl PR
J Am Acad Dermatol; 1999 Oct; 41(4):600-5. PubMed ID: 10495384
[TBL] [Abstract][Full Text] [Related]
16. Incompletely excised basal cell carcinoma: residual tumor rates at Mohs re-excision.
Palmer VM; Wilson PR
Dermatol Surg; 2013 May; 39(5):706-18. PubMed ID: 23294110
[TBL] [Abstract][Full Text] [Related]
17. Randomized, controlled surgical trial of preoperative tumor curettage of basal cell carcinoma in Mohs micrographic surgery.
Huang CC; Boyce S; Northington M; Desmond R; Soong SJ
J Am Acad Dermatol; 2004 Oct; 51(4):585-91. PubMed ID: 15389195
[TBL] [Abstract][Full Text] [Related]
18. Curettage-electrodesiccation treatment of basal cell carcinomas.
Kopf AW; Bart RS; Schrager D; Lazar M; Popkin GL
Arch Dermatol; 1977 Apr; 113(4):439-43. PubMed ID: 848972
[TBL] [Abstract][Full Text] [Related]
19. Presence of residual basal cell carcinoma in re-excised specimens is more probable when deep and lateral margins were positive.
Fernandes JD; de Lorenzo Messina MC; de Almeida Pimentel ER; Castro LG
J Eur Acad Dermatol Venereol; 2008 Jun; 22(6):704-6. PubMed ID: 18384541
[TBL] [Abstract][Full Text] [Related]
20. Intralesional cryosurgery for the treatment of basal cell carcinoma of the lower extremities in elderly subjects: a feasibility study.
Har-Shai Y; Sommer A; Gil T; Krausz J; Gal-Or N; Mettanes I; Lavi I; Eyal N; Brizgalin L; Taran A; Har-Shai L; Elmalach I
Int J Dermatol; 2016 Mar; 55(3):342-50. PubMed ID: 26749491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
